An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The primary objective of this 13-week clinical trial is to test the hypothesis that treatment
with Memantine will significantly improve the symptoms of those suffering from either bulimia
nervosa, purging type or suffering from body dysmorphic disorder.